Fresenius Stock - Weekly operations and strategy snapshot
17.06.2026 - 18:55:08 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 18:54 CET. Details in the imprint.
Fresenius (DE0005785604) is one of Germany's best-known healthcare groups with activities spanning hospitals, dialysis services and infusion therapies. With no fresh ad-hoc news on Wednesday, investors are taking a structured look at the company's operating setup and strategic positioning across its business segments.
Key figures and reports on Fresenius stock
Background information, key figures and official investor documents help frame the operational and strategic picture for Fresenius.
How the group is structured
Fresenius organizes its activities into several key areas, including acute care hospitals and related services, outpatient care offerings and products for infusion, transfusion and clinical nutrition. These operations are primarily based in Europe but reach patients globally through subsidiaries and partnerships.
According to company disclosures, Fresenius manages a broad network of facilities and services that range from hospital operations to home care support, aiming to cover large parts of the patient journey. This diversified setup is intended to balance cyclical swings in individual segments and stabilize the overall earnings base.
Operational focus on healthcare services
The group has traditionally generated a significant portion of its revenue from hospital and related healthcare services, which are closely tied to public and private reimbursement systems in its core markets. That exposure means national healthcare budgets and regulatory frameworks remain central operational parameters.
Alongside hospital services, Fresenius is involved in areas such as infusion therapies and medical products used in clinical and post-acute settings. These offerings are designed to support both in-patient and out-patient care, linking the company's manufacturing and services activities.
The product behind the stock
Fresenius generates a substantial part of its business with products and services for infusion therapy, transfusion and clinical nutrition, supplying hospitals and other care facilities with solutions, devices and related services that support patient treatment across acute and chronic conditions.
Where the stock trades today
The shares of Fresenius (DE0005785604) trade on Xetra at EUR 38.77 as of 06/16/2026, 11:39 CET.
Key facts on Fresenius stock
- Company: Fresenius SE & Co. KGaA
- ISIN: DE0005785604
- WKN: 578560
- Ticker: FRE
- Venue: Xetra
- Price (as of 06/16/2026, 11:39 CET): 38.77 EUR
- Market cap: 21,98 Mrd. EUR (as of 06/16/2026)
- Sector / Industry: Health Care - Healthcare Facilities & Services
- Index membership: DAX
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
